Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Thursday's Intraday Session

Author: Benzinga Insights | September 14, 2023 01:31pm

Gainers

  • First Wave BioPharma (NASDAQ:FWBI) shares moved upwards by 23.8% to $0.54 during Thursday's regular session. As of 13:30 EST, this security is trading at a volume of 121.0 million shares, making up 4158.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.8 million.
  • Synlogic (NASDAQ:SYBX) stock moved upwards by 23.67% to $0.3. The current volume of 316.6K shares is 163.6% of Synlogic's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $20.9 million.
  • ENDRA Life Sciences (NASDAQ:NDRA) stock moved upwards by 22.79% to $1.25. Trading volume for ENDRA Life Sciences's stock is 2.0 million as of 13:30 EST. This is 3431.1% of its average full-day volume over the last 100 days. The company's market cap stands at $9.3 million.
  • NeuBase Therapeutics (NASDAQ:NBSE) stock moved upwards by 19.52% to $1.47. As of 13:30 EST, NeuBase Therapeutics's stock is trading at a volume of 8.1 million, which is 377.5% of its average full-day volume over the last 100 days. The company's market cap stands at $4.5 million.
  • Eloxx Pharmaceuticals (NASDAQ:ELOX) shares rose 18.53% to $5.5. The current volume of 69.1K shares is 7.1% of Eloxx Pharmaceuticals's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $15.1 million.
  • HeartBeam (NASDAQ:BEAT) shares moved upwards by 17.52% to $2.28. HeartBeam's stock is trading at a volume of 289.2K shares as of 13:30 EST. This is 275.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $59.9 million.

Losers

  • Biolase (NASDAQ:BIOL) shares fell 38.5% to $2.0 during Thursday's regular session. Trading volume for Biolase's stock is 1.2 million as of 13:30 EST. This is 562.9% of its average full-day volume over the last 100 days. The company's market cap stands at $2.0 million.
  • TransCode Therapeutics (NASDAQ:RNAZ) shares fell 22.23% to $0.7. Trading volume for TransCode Therapeutics's stock is 5.9 million as of 13:30 EST. This is 3983.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.4 million.
  • Bionomics (NASDAQ:BNOX) shares fell 21.79% to $1.4. Trading volume for this security as of 13:30 EST is 516.0K, which is 231.2% of its average full-day volume over the last 100 days. The company's market cap stands at $11.4 million.
  • ZyVersa Therapeutics (NASDAQ:ZVSA) shares declined by 21.11% to $0.15. Trading volume for this security as of 13:30 EST is 17.8 million, which is 413.6% of its average full-day volume over the last 100 days. The company's market cap stands at $4.6 million.
  • Harpoon Therapeutics (NASDAQ:HARP) stock decreased by 20.18% to $5.22. Trading volume for this security as of 13:30 EST is 188.0K, which is 635.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $21.0 million.
  • Novo Integrated Sciences (NASDAQ:NVOS) stock decreased by 19.26% to $0.36. As of 13:30 EST, this security is trading at a volume of 51.9 million shares, making up 126.3% of its average full-day volume over the last 100 days. The company's market cap stands at $56.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BEAT BIOL BNOX ELOX FWBI HARP NBSE NDRA NVOS RNAZ SYBX ZVSA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist